|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61P 35/00 |
| (11) | Number of the document | 3368067 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16795498.1 |
| Date of filing the European patent application | 2016-10-31 | |
| (97) | Date of publication of the European application | 2018-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/059680 |
| Date | 2016-10-31 |
| (87) | Number | WO 2017/075570 |
| Date | 2017-05-04 |
| (30) | Number | Date | Country code |
| 201562248964 P | 2015-10-30 | US |
| (72) |
WOOD, Lauren, V., US
ROBERSON, Brenda, D., US
BERZOFSKY, Jay, A., US
MORRIS, John, C., US
STEEL, Jason, C., AU
TERABE, Masaki, US
BRENNER, Malcolm K., US
|
| (73) |
Baylor College of Medicine,
One Baylor Plaza, Houston, TX 77030,
US
The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20852-7660, US |
| (54) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS |